Literature DB >> 12816332

Service utilization and outcomes in medically ill veterans with posttraumatic stress and depressive disorders.

Teresa L Kramer1, Brenda M Booth, Xiaotong Han, D Keith Williams.   

Abstract

This study examined behavioral health service utilization, health-related quality of life, and psychological distress in medically hospitalized male veterans (N = 743) with and without current or lifetime comorbid posttraumatic stress disorder (PTSD) and depressive disorder. Participants completed psychiatric and psychosocial self-report measures at baseline and follow-up. Clinical/functional status and service utilization rates were compared for patients with PTSD only, depressive disorder only, comorbid PTSD/depressive disorder, and neither disorder. Patients with PTSD/depressive disorder were more likely to use mental health/substance abuse services, have longer lengths of stay, and report more psychological distress than others. Results indicate that screening, early detection, and referral are critical in treating these comorbid patients because of increased psychological distress and high service-use rates.

Entities:  

Mesh:

Year:  2003        PMID: 12816332     DOI: 10.1023/A:1023783705062

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  13 in total

1.  Long-term effectiveness of collaborative depression care in older primary care patients with and without PTSD symptoms.

Authors:  Domin Chan; Ming-Yu Fan; Jürgen Unützer
Journal:  Int J Geriatr Psychiatry       Date:  2010-12-09       Impact factor: 3.485

2.  Social rhythm regularity moderates the relationship between sleep disruption and depressive symptoms in veterans with post-traumatic stress disorder and major depressive disorder.

Authors:  Elaine M Boland; Jennifer R Goldschmied; Monica R Kelly; Suzanne Perkins; Philip R Gehrman; Patricia L Haynes
Journal:  Chronobiol Int       Date:  2019-08-01       Impact factor: 2.877

Review 3.  Sleep disturbances, TBI and PTSD: Implications for treatment and recovery.

Authors:  Karina Stavitsky Gilbert; Sarah M Kark; Philip Gehrman; Yelena Bogdanova
Journal:  Clin Psychol Rev       Date:  2015-06-03

Review 4.  Disability and quality of life in post-traumatic stress disorder: impact of drug treatment.

Authors:  Soraya Seedat; Christine Lochner; Bavanisha Vythilingum; Dan J Stein
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  Understanding the relationship between co-occurring PTSD and MDD: symptom severity and affect.

Authors:  Loren M Post; Lori A Zoellner; Eric Youngstrom; Norah C Feeny
Journal:  J Anxiety Disord       Date:  2011-08-10

Review 6.  Treating nightmares and insomnia in posttraumatic stress disorder: a review of current evidence.

Authors:  Carla M Nappi; Sean P A Drummond; Joshua M H Hall
Journal:  Neuropharmacology       Date:  2011-03-17       Impact factor: 5.250

7.  Assessing and treating co-occurring disorders in adolescents: examining typical practice of community-based mental health and substance use treatment providers.

Authors:  David P Lichtenstein; Anthony Spirito; Rupa P Zimmermann
Journal:  Community Ment Health J       Date:  2009-09-19

8.  Trauma exposure influences cue elicited affective responses among smokers with and without a history of major depression.

Authors:  Dennis E McChargue; Alicia K Klanecky; Kate Walsh; David DiLillo
Journal:  Addict Behav       Date:  2008-05-09       Impact factor: 3.913

9.  Change in sleep symptoms across Cognitive Processing Therapy and Prolonged Exposure: a longitudinal perspective.

Authors:  Cassidy A Gutner; Melynda D Casement; Karina Stavitsky Gilbert; Patricia A Resick
Journal:  Behav Res Ther       Date:  2013-10-07

10.  Brief treatment of co-occurring post-traumatic stress and depressive symptoms by use of accelerated resolution therapy(®).

Authors:  Kevin E Kip; Kelly L Sullivan; Cecile A Lengacher; Laney Rosenzweig; Diego F Hernandez; Rajendra Kadel; Frank A Kozel; Amy Shuman; Sue Ann Girling; Marian J Hardwick; David M Diamond
Journal:  Front Psychiatry       Date:  2013-03-08       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.